From AI Insider · Greg Bock · · 1m 30s
TL;DR: Remedy Robotics Secures $62M for AI Vascular Robot
Remedy Robotics gets $62 million to build AI robot for stroke treatment.
Remedy Robotics raised $62 million in Series B funding to advance its AI-enabled N1 robotic system toward clinical trials and potential FDA approval for neurovascular procedures including stroke treatment. Remedy Robotics gets $62 million to build AI robot for stroke treatment. The DCVC-led round included UC Investments, Skip Capital, Hostplus and existing investors, with proceeds supporting a planned University of California clinical trial, prototype deployments…
- Funding Round Details
- Investors and Use of Funds
- N1 System Capabilities
- CEO's Statement
Read the story version — the same reporting as a swipeable deck of 6 cards.





